Medicare Enrolled
Dr. Sherly Pardo-Reoyo, M.D.
Clinical Cytogenetics Physician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pardo-Reoyo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pardo-Reoyo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pardo-Reoyo
Dr. Sherly Pardo-Reoyo is a clinical cytogenetics physician in New York, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Pardo-Reoyo performed 2,347 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Pardo-Reoyo received a total of $4,958 from 60 pharmaceutical and/or device companies across 244 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pardo-Reoyo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ 2,347 Medicare services
$4,958 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,347
Medicare services
1.0× state median for clinical cytogenetics physician
Not available
Unique patients (not deduplicated)
$152
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| CT guidance for radiation therapy This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery. |
592 | $88 | $198 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
431 | $256 | $1,600 |
| Radiation therapy, 3+ areas, 11-19 MeV Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators. |
287 | $168 | $480 |
| Calculation of radiation therapy dose | 177 | $49 | $280 |
| Radiation treatment management, 5 sessions Oversight and management of a radiation therapy course consisting of five treatment sessions. |
169 | $146 | $400 |
| Continuing radiation therapy consultation per week A weekly consultation to review and manage ongoing radiation therapy treatment. |
166 | $61 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $60 | $150 |
| Design and construction of complex radiation treatment device This code covers the design and construction of a complex radiation treatment device. It does not specify the clinical purpose or conditions treated. |
144 | $90 | $450 |
| Complex radiation therapy planning | 46 | $122 | $420 |
| High precision radiation therapy planning This procedure involves the detailed planning and setup required for delivering high-precision radiation therapy to a target area of the body. |
31 | $1,330 | $3,100 |
| Design and construction of radiation treatment device This code covers the design and construction of a device used for high precision radiation therapy. It does not include the actual administration of radiation treatment. |
31 | $344 | $1,200 |
| 3D radiation therapy planning This procedure involves creating a three-dimensional treatment plan for radiation therapy. It uses imaging data to map the target area and surrounding tissues to guide precise radiation delivery. |
24 | $354 | $1,500 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
22 | $195 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $120 | $250 |
| Radiation treatment planning, complex This procedure involves obtaining the necessary data to develop an optimal radiation treatment plan for three or more treatment areas, or any number of areas requiring special treatment. |
19 | $305 | $900 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $69 | $175 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
13 | $21 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,958
Total received (2018-2024)
Avg $708/year across 7 years
Top 0% in NY for clinical cytogenetics physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
244
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,984
2023
$1,014
2022
$928
2021
$660
2020
$156
2019
$107
2018
$108
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$321
Novartis Pharmaceuticals Corporation
$258
Tempus AI, Inc
$142
Daiichi Sankyo Inc.
$137
Janssen Biotech, Inc.
$118
Boston Scientific Corporation
$105
EMD Serono, Inc.
$88
PharmaEssentia USA Corporation
$84
PFIZER INC.
$84
PUMA BIOTECHNOLOGY, INC.
$65
Stemline Therapeutics Inc.
$62
Octapharma USA, Inc.
$46
Dendreon Pharmaceuticals LLC
$42
Eisai Inc.
$35
ABBVIE INC.
$33
JAZZ PHARMACEUTICALS INC.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$29
Alexion Pharmaceuticals, Inc.
$23
Pharmacosmos Therapeutics Inc.
$22
TerSera Therapeutics LLC
$22
Incyte Corporation
$21
Acrotech Biopharma Inc.
$21
Novocure Inc.
$21
ARRAY BIOPHARMA INC
$20
Celgene Corporation
$20
Lilly USA, LLC
$19
Coherus Biosciences Inc.
$19
Merck Sharp & Dohme LLC
$18
Regeneron Healthcare Solutions, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$17
Myriad Genetic Laboratories, Inc.
$17
Sumitomo Pharma America, Inc.
$14
Apellis Pharmaceuticals, Inc.
$13
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$662
AstraZeneca Pharmaceuticals LP
$563
Amgen Inc.
$212
Daiichi Sankyo Inc.
$191
Eisai Inc.
$177
Novocure Inc.
$159
Janssen Biotech, Inc.
$154
Tempus AI, Inc
$142
PharmaEssentia USA Corporation
$125
Merck Sharp & Dohme LLC
$120
Varian Medical Systems, Inc.
$108
Seagen Inc.
$107
Lilly USA, LLC
$105
Boston Scientific Corporation
$105
Incyte Corporation
$105
Takeda Pharmaceuticals U.S.A., Inc.
$103
EMD Serono, Inc.
$102
Dendreon Pharmaceuticals LLC
$96
Merck Sharp & Dohme Corporation
$95
Celgene Corporation
$84
PFIZER INC.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
Sobi, Inc
$66
PUMA BIOTECHNOLOGY, INC.
$65
Octapharma USA, Inc.
$65
Karyopharm Therapeutics Inc.
$63
Blue Earth Diagnostics Limited
$62
Stemline Therapeutics Inc.
$62
SOBI, INC
$61
GENZYME CORPORATION
$52
Progenics Pharmaceuticals, Inc.
$46
ADC Therapeutics America, Inc.
$45
Myovant Sciences Inc.
$45
E.R. Squibb & Sons, L.L.C.
$44
Kite Pharma, Inc.
$40
Coherus Biosciences Inc.
$39
Janssen Scientific Affairs, LLC
$34
ABBVIE INC.
$33
Epizyme, Inc.,
$33
JAZZ PHARMACEUTICALS INC.
$33
Bayer HealthCare Pharmaceuticals Inc.
$33
Sumitomo Pharma America, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$31
Alexion Pharmaceuticals, Inc.
$23
Pharmacyclics LLC, an AbbVie Company
$22
Pharmacosmos Therapeutics Inc.
$22
TerSera Therapeutics LLC
$22
Adaptive Biotechnologies Corporation
$22
Acrotech Biopharma Inc.
$21
ARRAY BIOPHARMA INC
$20
TOLMAR Pharmaceuticals, Inc.
$18
Clovis Oncology, Inc.
$18
Myriad Genetic Laboratories, Inc.
$17
Taiho Oncology, Inc.
$17
Acrotech Biopharma LLC
$15
Pharmacyclics LLC, An AbbVie Company
$15
Dova Pharmaceuticals
$15
BeiGene USA, Inc.
$13
Apellis Pharmaceuticals, Inc.
$13
AVEO Pharmaceuticals, Inc.
$12
Top 3 companies account for 29.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · Axumin · BAVENCIO · BELEODAQ · BESREMI · BRUKINSA · Blincyto · CALQUENCE · DARZALEX · DOPTELET · Doptelet · ELIGARD · ERLEADA · Empaveli · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · Halcyon · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONOFERRIC · MYRISK · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · OPDUALAG · ORGOVYX · Oncology · Optune · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROVENGE · PYLARIFY · Quzyttir · REBLOZYL · RYBREVANT · SpaceOAR VUE System - 10mL · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TIVDAK · ULTOMIRIS · Udenyca · VERZENIO · Vectibix · XGEVA · XPOVIO · XTANDI · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Clinical cytogenetics physicians in nearby ZIP areas
10
County median income
$104,553
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pardo-Reoyo is a clinical cardiology specialist, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pardo-Reoyo experienced with ct guidance for radiation therapy?
Based on Medicare claims data, Dr. Pardo-Reoyo performed 592 ct guidance for radiation therapy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pardo-Reoyo receive payments from pharmaceutical companies?
Yes. Dr. Pardo-Reoyo received a total of $4,958 from 60 companies across 244 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pardo-Reoyo's costs compare to other clinical cytogenetics physicians in New York?
Dr. Pardo-Reoyo's average Medicare payment per service is $152. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pardo-Reoyo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical Cytogenetics Physicians in New York
Browse clinical cytogenetics physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Clinical Cytogenetics Physicians in NY
Clinical cytogenetics physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical Cytogenetics Physicians in NY
Which NY clinical cytogenetics physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology